Lumexa Imaging (NASDAQ:LMRI) Raised to "Strong-Buy" at Raymond James Financial

Lumexa Imaging (NASDAQ:LMRI - Get Free Report) was upgraded by equities researchers at Raymond James Financial from an "outperform" rating to a "strong-buy" rating in a research note issued to investors on Monday, MarketBeat reports. The brokerage presently has a $23.00 price objective on the stock. Raymond James Financial's target price points to a potential upside of 112.96% from the company's current price.Get Lumexa Imaging alerts:Lumexa Imaging Stock Up 6.5%LMRI opened at $10.80 on Monday. Lumexa Imaging has a twelve month low of $9.97 and a twelve month high of $19.45. Institutional Trading of Lumexa ImagingAn institutional investor recently bought a new position in Lumexa Imaging stock. Assetmark Inc. acquired a new position in Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund acquired 1,957 shares of the company's stock, valued at approximately $36,000. About Lumexa Imaging (Get Free Report)We are one of the largest national providers of diagnostic imaging services(1). Our platform is integrated, scalable and has a proven track record of creating value for our stakeholders. As of September 30, 2025, we and our affiliates operated the second largest(1) outpatient imaging center footprint in the United States. It spans 184 centers(2) across 13 states and includes eight joint venture partnerships with health systems. Our centers are in attractive metropolitan statistical areas (“MSAs”).See AlsoFive stocks we like better than Lumexa ImagingYour Bank Account Is No Longer SafeThe day the gold market brokeWhat a Former CIA Agent Knows About the Coming CollapseHe just nailed another gold prediction …~$1.5T SpaceX IPO: Pre-IPO OpportunityThis instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.Should You Invest $1,000 in Lumexa Imaging Right Now?Before you consider Lumexa Imaging, you'll want to hear this.MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lumexa Imaging wasn't on the list.While Lumexa Imaging currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.View The Five Stocks Here